Attached files
file | filename |
---|---|
10-K - ARRHYTHMIA RESEARCH 2009 10K - MICRON SOLUTIONS INC /DE/ | art200910k.htm |
EX-23.1 - EX23-1 AUDITORS CONSENT - MICRON SOLUTIONS INC /DE/ | exhibit23-1.htm |
EX-32.2 - EX32-2 CERTIFICATION OF CFO SEC906 SOX 2002 - MICRON SOLUTIONS INC /DE/ | exhibit32-2.htm |
EX-32.1 - EX32-1 CERTIFICATION OF CEO SEC906 SOX 2002 - MICRON SOLUTIONS INC /DE/ | exhibit32-1.htm |
EX-31.2 - EX31-1 CERTIFICATION OF CFO - MICRON SOLUTIONS INC /DE/ | exhibit31-2.htm |
Exhibit
31.1
|
OFFICER’S
CERTIFICATION
|
|
PURSUANT
TO SECTION 302 OF
|
|
THE
SARBANES-OXLEY ACT OF 2002
|
I, James
E. Rouse, certify that:
1.
|
I
have reviewed this report on Form 10-K of Arrhythmia Research Technology,
Inc. for the fiscal year ended December 31,
2009;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the issuer as
of, and for, the periods presented in this
report;
|
4.
|
The
issuer’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d -15(f)) for the issuer and
have:
|
a.
|
designed
such disclosure controls and procedures or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that
material information relating to the issuer, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being
prepared;
|
b.
|
designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under my supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
c.
|
evaluated
the effectiveness of the issuer’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by
this report based on our
evaluation;
|
d.
|
disclosed
in this report any change in the issuer’s internal controls over financial
reporting that occurred during the issuer’s fourth fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the
issuer’s internal controls over financial reporting;
and
|
5.
|
The
issuer’s other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to
the issuer’s auditors and the audit committee of the issuer’s board of
directors (or persons performing the equivalent
functions):
|
a.
|
All
significant deficiencies in the design or operation of internal control
over financial reporting which are reasonably likely to adversely affect
the issuer’s ability to record, process, summarize and report financial
information; and,
|
b.
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the issuer’s internal controls
over financial reporting.
|
DATE:
March 10,
2010 /s/ James E.
Rouse
James E.
Rouse
President
and Chief Executive Officer